Abstract:Background Soluble fms-like tyrosine kinase-1(sFlt-1),a soluble secreted variant of the vascular endothelial growth factor(VEGF)receptor-1 that possesses only its extracellular domain,is a specific endogenous inhibitor of VEGF.Research showed that sFlt-1 is involved in retinal vasculogenesis.ObjectivePurpose of this study was to determine the effect of sFlt-1 gene on retinal neovascularization in vivo.MethodsLentiviral expression plasmid carrying the sFlt-1 gene fragment was constructed by RT-PCR and co-transfected HEK293 T cells by calcium phosphate-DNA coprecipitation method to obtain the recombinant lenti sFlt-1.Retinal neovascularization models were induced by exposing 36 C57BL/6J mice aged postnatal day 7(P7)to the hyperoxia(75%O2)environment for 5 days and then returning to normoxia(21%O2).Other 18 normal matched mice were raised in normoxia environment.1μL lenti-GFP or lenti.sFlt-1(with the virus titer 5×108 TU/mL)was intravitreously injected in P12-day mice in lenti-GFP group or lenti.sFlt-1 group(18 mice for each group)respectively,and the same volume of PBS was used at the same way in normal control group.The animals were sacrificed in P17 and hematoxylin-eosin staining was used to calculate the number of vascular endothelial cells nuclei breaking retinal inner limiting membrane.Retinal neovascular formation was observed in P17 mice after infusion of left ventricle of FITC-dextran under the fluorescence microscope.The expression of VEGF and KDR/Flk-1 in retinal tissue was detected by immunochemistry.The use of experimental animals followed the Standard of Association for Research in Vision and Ophthalmology.ResultsThe sequence of target gene fragment amplified by RT-PCR was consistent with standardized one in GenBank.sFlt-1 protein was expressed in human RPE cells after infected.The numbers of vascular endothelial cells nuclei breaking retinal inner limiting membrane were(47.26±6.76)in model group and(5.21±1.93)in lentivirus sFlt-1 group,showing a significant difference between them(P0.05).Many new blood vessels and leakage of fluorescine were seen in model mice,however,the new vessels were decreased in lentivirus sFlt-1 group under the fluorescence microscope.The expressions of VEGF and KDR/Flk-1 was obviously upregulated in model group compared with normal control group,but those in lenti.sFlt-1 group showed a low expression in comparison with normal control group.ConclusionLentivirus-mediated sFlt-1 gene inhibits retinal neovascularization in anoxia mouse.

Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immune responses

Evaluation on Monocyte-Mediated Delivery of a Therapeutic Gene into the Inflamed Brain.

Analysis of hepatic lentiviral vector transduction; implications on preclinical studies and clinical gene therapy protocols.

Analysis of hepatic lentiviral vector transduction; implications for preclinical studies and clinical gene therapy protocols

The Glymphatic System Delivery Enhances the Transduction Efficiency of AAV1 to Brain Endothelial Cells in Adult Mice.

Immune responses to central nervous system directed adeno-associated virus gene therapy: Does direct CNS delivery make a difference?

Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes

Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors

Viral vectors for gene delivery to the central nervous system

Abortive and productive infection of CNS cell types following in vivo delivery of VSV

A Large U3 Deletion Causes Increased in Vivo Expression from a Nonintegrating Lentiviral Vector

Immune Responses to Viral Gene Therapy Vectors

Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization

Management of Neuroinflammatory Responses to AAV-Mediated Gene Therapies for Neurodegenerative Diseases

Enhanced AAV transduction across preclinical CNS models: A comparative study in human brain organoids with cross-species evaluations

Transduction of the central nervous system after intracerebroventricular injection of adeno-associated viral vectors in neonatal and juvenile mice

Clinically-derived vagus nerve stimulation enhances cerebrospinal fluid penetrance

Immune tolerance promotion by LSEC-specific lentiviral vector-mediated expression of the transgene regulated by the stabilin-2 promoter

Ultrasound-Mediated Blood-Brain Barrier Opening Improves Whole Brain Gene Delivery in Mice

Genome-Wide Analysis of Alpharetroviral Integration in Human Hematopoietic Stem/Progenitor Cells

Inhibitory Effects of Lentivirus-Mediated Sflt-1 Gene Transfer on Retinal Neovascularization